Catalog Number LAP-BAND ADJUSTABLE GASTRIC BA |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Cardiac Arrest (1762); Death (1802); Hemorrhage/Bleeding (1888)
|
Event Date 04/10/2012 |
Event Type
Death
|
Event Description
|
Reported events of death, "abdominal haemorrhaging", "cardiac arrest", and "fatal heart attack" within one patient following gastric band surgery from media article "mum died after gastric band operation", hannah jennings-parry, solihull news, solihull_news@mm.Co.Uk, may 19, 2014.Although the manufacturer of the device is unknown, it is allergan's approach to compliance to resolve all doubt in favor of reporting.
|
|
Manufacturer Narrative
|
Taper unknown.The author of the article was asked to return the product for a device analysis as well as to indicate the product serial number, the date of the event, and the implant and explant dates.This information has not yet been received by allergan.The connector type cannot be identified nor an assumption be made as to the type of connector associated with this complaint because no serial number or implant date was given.Visual examination may determine the connector type associated with this report.Allergan has not received the product at this time.Therefore, no analysis or testing has been done.Death, cardiopulmonary arrest, and hemorrhage are surgical and physiological complications, and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding the serial number and the implant date has been requested.Device labeling addresses the reported event of death as follows: "laparoscopic or laparotomic placement of the lap-band system is major surgery and death can occur." device labeling addresses the reported event of hemorrhage as follows: "specific complications of laparoscopic surgery can include spleen damage (sometimes requiring splenectomy) or liver damage, bleeding from major blood vessels, lung problems, thrombosis, and rupture of the wound." allergan also states in the dfu for the product: "precautions: it is the responsibility of the surgeon to advise the patient of the known risks and complications associated with the surgical procedure and implant.".
|
|
Search Alerts/Recalls
|
|